Logo
C

CHARM Therapeutics

51 employees

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.

Basic info

Industry

research services

Sectors

Biotechnology
Artificial Intelligence
Life Science

Date founded

2021

Funding rounds raised

Total raised

$50M

from 5 investors over 5 rounds

C

CHARM Therapeutics raised $50M on June 9, 2022

Investors: F-Prime Capital Partners, General Catalyst, Braavos Investment Advisers, OrbiMed Advisors and Khosla Ventures

FAQ